Learn More
Medchemexpress LLC Miglustat hydrochloride | 210110-90-0 | 98.0% | 255.74 | 100 MG

Supplier: Medchemexpress LLC HY17020A100MG
Miglustat hydrochloride is an orally active, reversible ceramide glucosyltransferase inhibitor with blood-brain barrier permeability. It is primarily used for the research of type I Gaucher disease. It also restores F508del-CFTR function in cystic fibrosis (CF) bronchial epithelial cells and reduces the inflammatory response to P. aeruginosa.
- Orally active
- Reversible ceramide glucosyltransferase inhibitor
- Crosses the blood-brain barrier
- Used in research for type I Gaucher disease
- Restores F508del-CFTR function in cystic fibrosis bronchial epithelial cells
- Reduces inflammatory response to P. aeruginosa
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.